| GC48770-1mg |
|
3 |
|
0 |
— |
|
|
|
| GC48770-100μg |
|
3 |
|
0 |
— |
|
|
|
| GC48769-10mg |
|
131021-99-3 |
7,10-dihydroxy-8(E)-Octadecenoic Acid
|
0 |
— |
|
|
|
| GC48769-5mg |
|
131021-99-3 |
7,10-dihydroxy-8(E)-Octadecenoic Acid
|
0 |
— |
|
|
|
| GC48769-1mg |
|
131021-99-3 |
7,10-dihydroxy-8(E)-Octadecenoic Acid
|
0 |
— |
|
|
|
| GC48768-1mg |
|
— |
|
0 |
— |
|
|
|
| GC48767-1mg |
|
31508-71-1 |
|
0 |
— |
|
|
|
| GC48766-1mg |
|
1184983-42-3 |
Cyclobenzaprine-d3 (hydrochloride) (CRM)
|
0 |
— |
|
|
|
| GC48765-100μg |
|
— |
Arachidonic Acid-d11 MaxSpec® Standard
|
0 |
— |
|
|
|
| GC48764-1mg |
|
58450-00-3 |
|
0 |
— |
|
|
|
| GC48764-250μg |
|
58450-00-3 |
|
0 |
— |
|
|
|
| GC48763-5mg |
|
1542211-40-4 |
|
0 |
— |
|
|
|
| GC48763-1mg |
|
1542211-40-4 |
|
0 |
— |
|
|
|
| GC48762-1mg |
|
— |
UR-144-d5 (exempt preparation)
|
0 |
— |
|
|
|
| GC48761-100μg |
|
— |
Alprazolam-d8 (exempt preparation)
|
0 |
— |
|
|
|
| GC48760-5mg |
|
1329496-63-0 |
Maprotiline-d3 (hydrochloride)
|
0 |
— |
|
|
|
| GC48760-1mg |
|
1329496-63-0 |
Maprotiline-d3 (hydrochloride)
|
0 |
— |
|
|
|
| GC48760-500μg |
|
1329496-63-0 |
Maprotiline-d3 (hydrochloride)
|
0 |
— |
|
|
|
| GC48759-1mg |
|
— |
|
0 |
— |
|
|
|
| GC48758-1mg |
|
81586-39-2 |
|
0 |
— |
|
|
|
